CDK4/6 and PI3K inhibitors: A new promise for patients with HER2-positive breast cancer.
Authors : Agostinetto E, Debien V, Marta GN, Lambertini M, Piccart-Gebhart M, de Azambuja E
Year : 2021
Journal : Eur J Clin Invest
Pages : e13535